Medicare is changing in 2027, and these changes could directly affect your coverage and costs. Many plans are adjusting premiums, copays, prescription coverage, and provider networks; many plans are even DISCONTINUING at the end of 2026. For patients, this could mean not having coverage, paying more than necessary or even losing access to trusted doctors and medications in 2027.
That’s why this year more than ever it is very important to carefully review your Medicare plan during the Annual Election Period (October 15 – December 7) to make sure you are set up with the most suitable plan for 2027.

Free Medicare Plan Reviews Through Heppner Group
To help you review your plan, Twin Cities Eye Consultants has partnered with Heppner Group, a free and trusted Medicare resource. Their team will:
- Review your current Medicare insurance plan in detail
- Make sure you will continue to have access to your doctors in 2027
- Confirm your prescriptions are covered under your plan in 2027
- Identify opportunities to lower your out-of-pocket costs
- Help you compare 2027 Medicare Advantage, Supplement, and Part D plans
- Explain how the 2027 changes may affect your care and finances
- Enroll you in the plan for 2027 that best fits your needs
- Provide year-round support, including annual reviews
This service comes at no cost to you, and you are not required to make any changes. It is simply a valuable resource to help ensure you have the most suitable coverage in 2027.
Schedule Your Medicare Plan Review
We suggest giving Heppner Group a call today at 651-315-7915 to schedule your review.
Additional Medicare Resources and Information
You can always contact Medicare.gov, 1-800-MEDICARE or your local, federally-funded State Health Insurance Program (SHIP) to obtain free information on all of your plan and coverage options. The Heppner Group and its agents are paid directly by the Medicare plan when enrollment occurs. The broker and its agents may not provide resources related to every plan in your area. No physicians receive financial benefit if patients work with third-party brokers and physicians do not endorse the use of a particular, or any such, broker.